Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells

Traditional tumor vaccination approaches mostly focus on activating dendritic cells (DCs) by providing them with a source of tumor antigens and/or adjuvants, which in turn activate tumor-reactive T cells. Novel biomaterial-based cancer immunotherapeutic strategies focus on directly activating and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Schluck, Marjolein, Hammink, Roel, Figdor, Carl G., Verdoes, Martijn, Weiden, Jorieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509561/
https://www.ncbi.nlm.nih.gov/pubmed/31130945
http://dx.doi.org/10.3389/fimmu.2019.00931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509561/
https://www.ncbi.nlm.nih.gov/pubmed/31130945
http://dx.doi.org/10.3389/fimmu.2019.00931

Ejemplares similares